KELLY MARTI: Open Payments
NPI 1619095270 · BRANSON, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,215 in 67 payments from 13 companies in 2025. Trend: 2023 $1,562 · 2024 $1,413 · 2025 $1,215
Food & beverage: $1,215
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 15 | $303 |
| Boston Scientific Corporation | 6 | $191 |
| Abbott Laboratories | 15 | $182 |
| Novartis Pharmaceuticals Corporation | 12 | $176 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 6 | $96 |
| ABIOMED | 3 | $71 |
| Amgen Inc. | 2 | $52 |
| Kestra Medical Technology Services, Inc. | 2 | $42 |
| Merck Sharp & Dohme LLC | 2 | $32 |
| Inspire Medical Systems, Inc. | 1 | $24 |
Products named: WATCHMAN FLX, LEQVIO, FARXIGA, LifeVest, LOKELMA, ASSURITY, GALLANT, REPATHA.
Industry payments across MO — which companies pay providers there.
